Could Heterozygous Beta Thalassemia Provide Protection Against Multiple Sclerosis?

Creative Commons License

Cikrikcioglu M. A., Ozcan M. E., Halac G., Gultepe I., Celik K., Sekin Y., ...More

MEDICAL SCIENCE MONITOR, vol.22, pp.4854-4858, 2016 (SCI-Expanded, Scopus)

  • Publication Type: Article / Article
  • Volume: 22
  • Publication Date: 2016
  • Doi Number: 10.12659/msm.898192
  • Journal Name: MEDICAL SCIENCE MONITOR
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.4854-4858
  • Keywords: beta-Thalassemia, Multiple Sclerosis, Platelet Aggregation, SYSTEMIC-LUPUS-ERYTHEMATOSUS, PLATELET ACTIVATION, TRAIT
  • Open Archive Collection: AVESIS Open Access Collection
  • Istanbul University Affiliated: No

Abstract

Background: Heterozygous beta thalassemia (HBT) has been proposed to increase the risk of developing autoimmune disease. Our aim in this study was to examine the prevalence of HBT among multiple sclerosis (MS) patients.